Abstract: |
A method was developed to prepare 5′‐deoxy‐5′‐substituted‐ψ‐uridine derivatives 4 from 3′,5′‐O‐(1, 1, 3, 3‐tetraisopropyldisiloxanyl)‐1,3‐dimethyl‐ψ‐uridine 1 via a silyl rearrangement reaction. Nucleophilic displacement of the mesyloxy function of 2′‐O‐mesyl‐1,3‐dimethyl‐ψ‐uridine 7 afforded products with the 2′‐substituent in the “down” ribo configuration 8. X‐Ray crystallographic analysis of the 2′‐chloro derivative 8a firmly established the molecular structure of 8 and provided evidence for neighboring group participation of the 4‐carbonyl function of 7 during the nucleophilic reactions. Treatment of 1,3‐dimethyl‐ψ‐uridine 11 with α‐acetoxyisobutyryl chloride afforded a mixture from which two 2′‐chloro‐2′‐deoxy‐C‐nucleosides were obtained. The major product (33% yield) was identical with 8. The minor product (7% yield) was consequently assigned the arabino nucleoside 14. This is the first direct introduction of a 2′‐substituent in the “up” configuration in a preformed pyrimidine nucleoside. Copyright © 1985 Journal of Heterocyclic Chemistry |
Keywords: |
nonhuman; drug structure; drug synthesis; nuclear magnetic resonance; theoretical study; drug identification; priority journal; drug analysis; 1,3 dimethylpseudouridine; 2' deoxy 1,3 dimethylpseudouridine; 2' deoxy 1,3 dimethylpseudouridine derivative; 3' deoxy 1,3 dimethylpseudouridine; 5' deoxy 1,3 dimethylpseudouridine; 5' deoxy 1,3 dimethylpseudouridine derivative
|